Isotretinoin and serum lipids: studies on fatty acid, apolipoprotein and intermediary metabolism
- 1 August 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 117 (2), 203-206
- https://doi.org/10.1111/j.1365-2133.1987.tb04117.x
Abstract
Thirteen patients with severe acne were treated for 16 weeks with 1·0 mg/kg/day isotretinoin. There were significant increases in serum cholesterol (P < 0·02), triglycerides (P < 0·02) and apolipoprotein B (P < 0·02). No changes were found in serum apolipoprotein A‐1, non‐esterified fatty acids (NEFA), carnitine, lactate, pyruvate, glycerol, alanine, beta‐hydroxy‐butyrate, glucose or insulin. We therefore found no evidence that the hyperlipidaemia of isotretinoin therapy is due to increased fluxes of NEFA from adipose tissue to the liver, although we cannot exclude the possibility that there are changes in the proportion of NEFA being esterified to triglyceride or undergoing beta‐oxidation. We suggest that the hyperlipidaemia induced by isotretinoin may be due to an increase in circulating lipoprotein from increased production or impaired catabolism.This publication has 6 references indexed in Scilit:
- Retinoids and Blood Lipids: An Update and ReviewPublished by S. Karger AG ,2015
- Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequencesBritish Journal of Dermatology, 1986
- A sequential comparison of etretinate (TigasonR) and isotretinoin (RoaccutaneR) with special regard to their effects on serum lipoproteinsBritish Journal of Dermatology, 1985
- Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid functionClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Effect of oral 13-cis-retinoic acid on serum lipidsBritish Journal of Dermatology, 1982
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979